The drug is indicated for the treatment of schizophrenia and for additional maintenance treatment of bipolar disorder.

FILE PHOTO: The Johnson & Johnson logo is displayed on a screen on the floor of the NYSE in New York (Reuters) - Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men ...

A jury in Philadelphia said Tuesday that Johnson & Johnson must pay $8 billion in punitive damages to a man who previously won $680,000 over his claims that the New Brunswick-based company failed to ...

A Philadelphia jury ordered Johnson & Johnson to pay $8 billion in punitive damages in a case accusing the drugmaker of downplaying the risks associated with its antipsychotic drug, Risperdal, ...

For nearly a decade, Toni Matthews-El has published business topics ranging from cloud communication software to best steps for establishing your own LLC. In addition to Forbes Advisor, she's ...

The FDA told Johnson & Johnson (JNJ) in 1997 that its request to market the antipsychotic drug Risperdal for children was "without any justification." In the following years, J&J's army of ...

Nearly three years after Philadelphia juries awarded compensatory damages in two Risperdal cases, a judge has ordered that the cases proceed to new trials on whether the drugmaker's conduct merits ...

A judge on Friday took an axe to a legal award against Johnson & Johnson — chopping the settlement from $8 billion to $6.8 million — in the case of a man who said the company failed to warn consumers ...

Johnson & Johnson's schizophrenia drug Risperdal at Skenderian Apothecary in Cambridge, Massachusetts, on Jan. 23, 2007. Photo: JB Reed/Bloomberg News. The Pennsylvania Supreme Court has ruled that ...

Johnson & Johnson, still reeling from settling two Ohio opioid-related lawsuits for more than $20 million, was slapped with an $8 billion judgment on Tuesday over its antipsychotic drug Risperdal. A ...